US FDA inspection at Lannett Company LLC concludes with four observations: Aurobindo Pharma
Hyderabad, Aug 24 (TNT): Aurobindo Pharma Limited on Monday informed stock exchanges that the United States Food and Drug Administration (US FDA) conducted a routine inspection at its wholly owned step-down subsidiary Lannett Company LLC in Seymour, Indiana, USA.
The inspection was conducted from August 17 to August 21, 2026 and concluded with four observations, which the company said were procedural in nature.
Aurobindo Pharma said it would submit its response to the US FDA within the stipulated timeline.
The Hyderabad based company said it remains committed to maintaining robust quality and compliance standards across its manufacturing facilities and will keep stock exchanges informed about further developments, as required under applicable regulations.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Lannett Company LLC is a wholly owned step-down subsidiary of Aurobindo Pharma USA Inc., according to the company filing.
TNT TS
